Literature DB >> 8870845

Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression.

H M Naif1, J Chang, M Ho-Shon, S Li, A L Cunningham.   

Abstract

The mechanism of inhibition of HIVBa-L replication by interleukin 10 (IL-10) in primary monocytes and macrophages at various stages of maturation was investigated using semiquantitative PCR for reverse-transcribed HIV DNA, and Northern hybridization for HIV mRNA expression in comparison with extracellular p24 antigen. Pretreatment of monocytes with IL-10 markedly inhibited expression of both unspliced and spliced HIV RNA, reaching a nadir at 7 days and recovering to normal levels by 10 days after a single application. The optimum inhibitory concentration was 25 ng/ml. Less inhibition of HIV RNA expression was observed when IL-10 was added after HIV infection of monocytes and the inhibitory effect progressively declined to negligible levels as monocytes matured into macrophages over 10 days. IL-10 also downregulated the expression of cellular genes, including the transferrin receptor, 28S rRNA, and GAPDH. The kinetics of the inhibition of cellular mRNAs correlated with the inhibition of HIV RNA and also declined as monocytes matured into macrophages. In contrast, IL-10 did not inhibit cellular mRNA expression in the macrophage cell line THP-1. Neutralizing polyclonal antibody to IL-10 reversed all its inhibitory effects. Interaction of IL-10 and TNF-alpha in combination were generally antagonistic in their effects on HIV transcription. IL-10 prevented stimulation of HIV RNA expression by TNF-alpha after preincubation with monocytes for 48 hr. IL-10 had no effect on the levels of HIV cDNA or the process of initiation and completion of reverse transcription. The inhibitory effect of IL-10 on HIV replication in maturing monocytes was probably mediated mainly by inhibition of cellular gene expression and inhibition of maturation of monocytes into macrophages and their activation, with consequent downregulation of HIV mRNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870845     DOI: 10.1089/aid.1996.12.1237

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Parasite virulence, co-infections and cytokine balance in malaria.

Authors:  Raquel Müller Gonçalves; Nathália Ferreira Lima; Marcelo Urbano Ferreira
Journal:  Pathog Glob Health       Date:  2014-05-23       Impact factor: 2.894

3.  Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.

Authors:  Justine K Wong; Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

4.  Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins.

Authors:  H M Naif; S Li; M Alali; J Chang; C Mayne; J Sullivan; A L Cunningham
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Regulation of bovine leukemia virus tax and pol mRNA levels by interleukin-2 and -10.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection.

Authors:  H M Naif; S Li; M Alali; A Sloane; L Wu; M Kelly; G Lynch; A Lloyd; A L Cunningham
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages.

Authors:  Gary D Ewart; Najla Nasr; Hassan Naif; Graeme B Cox; Anthony L Cunningham; Peter W Gage
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons.

Authors:  Viviana Cobos Jiménez; Thijs Booiman; Steven W de Taeye; Karel A van Dort; Maarten A N Rits; Jörg Hamann; Neeltje A Kootstra
Journal:  Sci Rep       Date:  2012-10-23       Impact factor: 4.379

10.  Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.

Authors:  Jairo R Temerozo; Rafael Joaquim; Eduardo G Regis; Wilson Savino; Dumith Chequer Bou-Habib
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.